title: The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.
abstract: BACKGROUND
  Probiotics are defined as live microorganisms that when administered in adequate amounts confer health benefits to the host. The consumption of probiotics has gained increasing recognition from the scientific community due to the promising effects on metabolic health through gut microbiota modulation.
  
  
  METHODS
  This article presents a review of scientific studies investigating probiotic species and their effects on different risk factors of the metabolic syndrome (MetS). This article also presents a summary of the major mechanisms involved with gut microbiota and the components of the MetS and raises the key issues to be considered by scientists in search of probiotics species for treatment of patients suffering from this metabolic disorder.
  
  
  CONCLUSIONS
  Probiotics may confer numerous health benefits to the host through positive gut microbiota modulation. The strain selection is the most important factor for determining health effects. Further studies may consider gut microbiota as a novel target for prevention and management of MetS components and other cardiovascular risks.
authors: University of Londrina, Health Sciences Graduate Department, Post Graduate Program in Health Sciences , Rua Robert Koch n. 60, Londrina, Paraná , Brazil.
authors: Bruna
authors: B
authors: Miglioranza Scavuzzi
authors: Lucia Helena da Silva
authors: LH
authors: Miglioranza
authors: Fernanda Carla
authors: FC
authors: Henrique
authors: Thanise
authors: T
authors: Pitelli Paroschi
authors: Marcell Alysson Batisti
authors: MA
authors: Lozovoy
authors: Andréa Name Colado
authors: AN
authors: Simão
authors: Isaias
authors: I
authors: Dichi
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D019587:Dietary Supplements; D000069196:Gastrointestinal Microbiome / Q000502:physiology; D006801:Humans; D024821:Metabolic Syndrome / Q000150:complications / Q000382:microbiology / Q000628:therapy*; D019936:Probiotics / Q000494:pharmacology*; D012307:Risk Factors
keywords: dysbiosis; dyslipidemia; gut microbiota; inflammation; insulin resistance; obesity